Olive Leaf Extracts Are a Natural Source of Advanced Glycation End Product Inhibitors

다국어 초록 (Multilingual Abstract)

Advanced glycation end products (AGEs), which are readily formed and accumulated with sustained hyperglycemia,contribute to the development of diabetic complications. As a consequence, inhibition of AGE formation constitutes an attractive therapeutic/preventive target. In the current study, we explored the phytochemical composition and the in vitro effect of two different olive leaf extracts (an aqueous and a methanolic) on AGE formation. The methanolic olive leaf extract inhibited fluorescent AGE formation in a bovine serum albumin (BSA)-ribose system, whereas the aqueous extract had no effect in both BSA-fructose and BSA-ribose systems. The phytochemical profile was investigated with liquid chromatographyultraviolet-visible (UV-Vis) diode array coupled to electrospray ionization multistage mass spectrometry (LC/DAD/ESIMSn).
Quantification of the major phenolic compounds was performed with high performance liquid chromatography with UV-Vis diode array detection and nuclear magnetic resonance spectroscopy. Among the major phenolic components (luteolin,hydroxytyrosol, luteolin-40-O-b-D-glucopyranoside, luteolin-7-O-b-D-glucopyranoside, and oleuropein), luteolin and luteolin-40-O-b-D-glucopyranoside were assigned as potent inhibitors of AGE formation. The extraction procedure greatly affects the composition and therefore the anti-glycation potential of olive leaves.

참고문헌 (Reference)

1 Kendall M, "Zero effect of multiple dosage of olive leaf supplements on urinary biomarkers of oxidative stress in healthy humans" 25 : 270-280, 2009

2 Charisiadis P, "Unprecedented ultra-high-resolution hydroxy group 1H NMR spectroscopic analysis of plant extracts" 74 : 2462-2466, 2011

3 Suzuki R, "Two flavone C-glycosides from the style of Zea mays with glycation inhibitory activity" 66 : 564-565, 2003

4 Matsuda H, "Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities" 11 : 5317-5323, 2003

5 Yamagishi SI, "Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes" 1820 : 663-671, 2012

6 Caruso D, "Rapid evaluation of phenolic component profile and analysis of oleuropein aglyeon in olive oil by atmospheric pressure chemical ionization-mass spectrometry (APCI-MS)" 48 : 1182-1185, 2000

7 Fu S, "Qualitative screening of phenolic compounds in olive leaf extracts by hyphenated liquid chromatography and preliminary evaluation of cytotoxic activity against human breast cancer cells" 397 : 643-654, 2010

8 Cumaog˘ lu A, "Polyphenolic extracts from Olea europea L. protect against cytokine-induced b-cell damage through maintenance of redox homeostasis" 14 : 325-334, 2011

9 Kontogianni VG, "Phenolic compounds and antioxidant activity of olive leaf extracts" 26 : 186-189, 2012

10 Peng X, "Naturally occurring inhibitors against the formation of advanced glycation end-products" 2 : 289-301, 2011

11 Fujiwara Y, "Natural compounds containing a catechol group enhance the formation of N e- (carboxymethyl)lysine of the Maillard reaction" 50 : 883-891, 2011

12 Nomura M, "Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G21PA6 adipose cells" 31 : 1403-1409, 2008

13 Wu CH, "Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts" 53 : 3167-3173, 2005

14 Kwon O, "Inhibition of the intestinal glucose transporter GLUT2 by flavonoids" 21 : 366-377, 2007

15 Kim JS, "Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid" 64 : 2458-2461, 2010

16 Ryan D, "Identification of phenolic compounds in tissues of the novel olive cultivar Hardy’s Mammoth" 50 : 6716-6724, 2002

17 Nicole E, "Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship" 18 : 2661-2672, 2011

18 Charisiadis P, "Exploring the ‘‘forgotten’’ -OH NMR spectral region in natural products" 46 : 3589-3591, 2010

19 Serra A, "Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake" 56 : 486-96, 2012

20 Soler A, "Digestion stability and evaluation of the metabolism and transport of olive oil phenols in the human small-intestinal epithelial Caco-2/TC7 cell line" 119 : 703-714, 2010

21 Freedman BI, "Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II)" 20 : 493-510, 1999

22 Ardestani A, "Cyperus rotundus suppresses AGE formation and protein oxidation in a model of fructose-mediated protein glycoxidation" 41 : 572-578, 2007

23 Benavente-Garcia O, "Antioxidant activity of phenolics extracted from Olea europaea L. leaves" 68 : 457-462, 2000

24 Sharma SD, "Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro" 6 : 233-242, 2002

25 Sourris KC, "A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?" 30 : 323-335, 2009

26 Quirantes-Pine´ R, "A metabolic- profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC-ESI-QTOF-MS" 72 : 121-126, 2013